• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对. 的噬菌体 GEC_vB_Bfr_UZM3 的特性分析

Characterization of a Bacteriophage GEC_vB_Bfr_UZM3 Active against .

机构信息

Laboratory of Microbial Biotechnology, Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia.

Department of Biology, Faculty of Exact and Natural Sciences, Javakhishvili Tbilisi State University, Tbilisi 0179, Georgia.

出版信息

Viruses. 2023 Apr 25;15(5):1042. doi: 10.3390/v15051042.

DOI:10.3390/v15051042
PMID:37243129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10222676/
Abstract

is a commensal gut bacterium that is associated with a number of blood and tissue infections. It has not yet been recognized as one of the drug-resistant human pathogens, but cases of the refractory infections, caused by strains that are not susceptible to the common antibiotic regimes established for have been more frequently reported. Bacteriophages (phages) were found to be a successful antibacterial alternative to antibiotic therapy in many cases of multidrug-resistant (MDR) bacterial infections. We have characterized the bacteriophage GEC_vB_Bfr_UZM3 (UZM3), which was used for the treatment of a patient with a chronic osteomyelitis caused by a mixed infection. Studied biological and morphological properties of UZM3 showed that it seems to represent a strictly lytic phage belonging to a siphovirus morphotype. It is characterized by high stability at body temperature and in pH environments for about 6 h. Whole genome sequencing analysis of the phage UZM3 showed that it does not harbor any known virulence genes and can be considered as a potential therapeutic phage to be used against infections.

摘要

是一种共生肠道细菌,与许多血液和组织感染有关。它尚未被认为是耐药性人类病原体之一,但越来越多的报道称,由对抗生素治疗方案不敏感的菌株引起的难治性感染病例。噬菌体(phages)在许多多重耐药(MDR)细菌感染的情况下被发现是一种替代抗生素治疗的成功抗菌方法。我们已经对噬菌体 GEC_vB_Bfr_UZM3(UZM3)进行了表征,该噬菌体用于治疗一名慢性骨髓炎患者,该患者的感染由混合感染引起。对 UZM3 的生物学和形态学特性进行的研究表明,它似乎代表一种严格的裂解噬菌体,属于丝状噬菌体形态型。它在体温和 pH 环境下约 6 小时内具有高度稳定性。噬菌体 UZM3 的全基因组测序分析表明,它不携带任何已知的毒力基因,可以被认为是一种潜在的治疗性噬菌体,可用于对抗感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/4925ed477ee8/viruses-15-01042-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/85172f837d14/viruses-15-01042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/cbba7e0653f7/viruses-15-01042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/fa026252a925/viruses-15-01042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/382ddf0b6d3c/viruses-15-01042-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/4925ed477ee8/viruses-15-01042-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/85172f837d14/viruses-15-01042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/cbba7e0653f7/viruses-15-01042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/fa026252a925/viruses-15-01042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/382ddf0b6d3c/viruses-15-01042-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/10222676/4925ed477ee8/viruses-15-01042-g006.jpg

相似文献

1
Characterization of a Bacteriophage GEC_vB_Bfr_UZM3 Active against .针对. 的噬菌体 GEC_vB_Bfr_UZM3 的特性分析
Viruses. 2023 Apr 25;15(5):1042. doi: 10.3390/v15051042.
2
Genome Characterization of a Novel Wastewater Bacteriophage (vB_BfrS_23) and its Host GB124.新型废水噬菌体(vB_BfrS_23)及其宿主GB124的基因组特征分析
Front Microbiol. 2020 Oct 23;11:583378. doi: 10.3389/fmicb.2020.583378. eCollection 2020.
3
SELECTION OF THE ACTIVE PHAGES AGAINST B.FRAGILIS FOR FURTHER STUDY OF THRAPEUTIC PERPECTIVES.选择针对脆弱拟杆菌的活性噬菌体以进一步研究治疗前景。
Georgian Med News. 2018 Dec(285):111-116.
4
In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Infection.噬菌体 VA7 抗肠毒素感染治疗潜力的体外评价。
Viruses. 2021 Oct 11;13(10):2044. doi: 10.3390/v13102044.
5
Novel lytic bacteriophage vB_GEC_EfS_9 against Enterococcus faecium.新型裂解性噬菌体vB_GEC_EfS_9,针对粪肠球菌
Virus Res. 2022 Jan 2;307:198599. doi: 10.1016/j.virusres.2021.198599. Epub 2021 Oct 12.
6
Bacteriophages of Bacteroides.拟杆菌属的噬菌体
Rev Infect Dis. 1979 Mar-Apr;1(2):325-36. doi: 10.1093/clinids/1.2.325.
7
Phage vB_Ec_ZCEC14 to treat antibiotic-resistant Escherichia coli isolated from urinary tract infections.噬菌体 vB_Ec_ZCEC14 治疗尿路感染中分离出的抗药性大肠杆菌。
Virol J. 2024 Feb 16;21(1):44. doi: 10.1186/s12985-024-02306-0.
8
A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates.一种新型 N4 样噬菌体,从印度南部的废水来源中分离出来,对几种多药耐药临床铜绿假单胞菌分离株具有活性。
mSphere. 2021 Jan 13;6(1):e01215-20. doi: 10.1128/mSphere.01215-20.
9
Isolation of a Virulent subsp. Bacteriophage and Its Application in Phage Therapy in Turbot ().一株溶藻弧菌烈性噬菌体的分离及其在大菱鲆噬菌体疗法中的应用()。
Appl Environ Microbiol. 2021 Oct 14;87(21):e0146821. doi: 10.1128/AEM.01468-21. Epub 2021 Aug 18.
10
Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms.脆弱拟杆菌碳青霉烯类耐药:分子机制综述。
Anaerobe. 2022 Aug;76:102606. doi: 10.1016/j.anaerobe.2022.102606. Epub 2022 Jun 20.

引用本文的文献

1
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.100 例连续病例的个体化噬菌体治疗结果:一项多中心、多国、回顾性观察研究。
Nat Microbiol. 2024 Jun;9(6):1434-1453. doi: 10.1038/s41564-024-01705-x. Epub 2024 Jun 4.
2
Isolation and characterization of a novel lytic bacteriophage φPDS1 from the human gut.从人体肠道中分离和鉴定一种新型裂解噬菌体 φPDS1。
Gut Microbes. 2024 Jan-Dec;16(1):2298254. doi: 10.1080/19490976.2023.2298254. Epub 2024 Jan 4.

本文引用的文献

1
Novel Bacteriophage Specific against and with Antibiofilm Activity.新型噬菌体特异性针对 并具有抗生物膜活性。
Viruses. 2022 Jun 20;14(6):1340. doi: 10.3390/v14061340.
2
Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms.脆弱拟杆菌碳青霉烯类耐药:分子机制综述。
Anaerobe. 2022 Aug;76:102606. doi: 10.1016/j.anaerobe.2022.102606. Epub 2022 Jun 20.
3
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
4
In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Infection.噬菌体 VA7 抗肠毒素感染治疗潜力的体外评价。
Viruses. 2021 Oct 11;13(10):2044. doi: 10.3390/v13102044.
5
Mechanisms and clinical importance of bacteriophage resistance.噬菌体耐药性的机制及临床重要性。
FEMS Microbiol Rev. 2022 Feb 9;46(1). doi: 10.1093/femsre/fuab048.
6
PHROG: families of prokaryotic virus proteins clustered using remote homology.PHROG:利用远缘同源性聚类的原核病毒蛋白家族。
NAR Genom Bioinform. 2021 Aug 5;3(3):lqab067. doi: 10.1093/nargab/lqab067. eCollection 2021 Sep.
7
Recombinant enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways.重组肠毒素-1(rBFT-1)通过CCL3相关分子途径促进结直肠癌的增殖。
Open Life Sci. 2021 Apr 27;16(1):408-418. doi: 10.1515/biol-2021-0043. eCollection 2021.
8
Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.脆弱拟杆菌的临床和结直肠标本分离株的抗生素耐药模式。
Ann Clin Microbiol Antimicrob. 2021 Apr 23;20(1):27. doi: 10.1186/s12941-021-00435-w.
9
Protein Sequence Analysis Using the MPI Bioinformatics Toolkit.使用 MPI 生物信息学工具包进行蛋白质序列分析。
Curr Protoc Bioinformatics. 2020 Dec;72(1):e108. doi: 10.1002/cpbi.108.
10
Genome Characterization of a Novel Wastewater Bacteriophage (vB_BfrS_23) and its Host GB124.新型废水噬菌体(vB_BfrS_23)及其宿主GB124的基因组特征分析
Front Microbiol. 2020 Oct 23;11:583378. doi: 10.3389/fmicb.2020.583378. eCollection 2020.